Skip navigation
Skip navigation

Bone turnover 18 months after a single intravenous dose of zoledronic acid

Borba, LuizAlencar; Da Paz Filho, Gilberto; kulak, carolina A; Seibel, Markus J.; Bilezikian, John P


Zoledronic acid inhibits bone resorption for up to 12 months. It is not known whether the duration of this antiresorptive effect extends beyond this period of time. The aim of this study was to evaluate the changes in bone turnover at 12 months (T12) and

CollectionsANU Research Publications
Date published: 2007
Type: Journal article
Source: International Journal of Clinical Practice
DOI: 10.1111/j.1742-1241.2007.01392.x


File Description SizeFormat Image
01_Borba_Bone_turnover_18_months_after_2007.pdf179.52 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator